Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains

Veterinary Microbiology

Volumn 126, Issue 1-3, 2008, Pages 40-50

  Mahapatra, M ^a   Aggarwal, N ^a   Cox, S ^a   Statham, R J ^a   Knowles, N J ^a   Barnett, P V ^a   Paton, D J ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

FMD virus; Monoclonal antibodies; Polyclonal antibodies; Vaccine selection

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; MONOCLONAL ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETIC VARIABILITY; GEOGRAPHY; NONHUMAN; SEROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CAPSID PROTEINS; CELL LINE; FOOT-AND-MOUTH DISEASE VIRUS; MOLECULAR SEQUENCE DATA; VIRAL VACCINES;

FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

EID: 36549081843     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2007.06.022     Document Type: Article

References (23)

1. Aktas S., and Samuel A.R. Identification of antigenic epitopes on the foot and mouth disease virus isolate O-1/Manisa/Turkey/69 using monoclonal antibodies. Rev. Sci. Techn. Off. Int. Epizoot. 19 (2000) 744-753
2. Alonso F.A., Casas Olascoaga R.C., Astudillo V.M., Sondahl M.S., Gomes I., and Vianna Filho Y.L. Updating of foot and mouth disease virus strains of epidemiological importance in South America. Bol. Cent. Panam. Fiebre aftosa 53 (1987) 11-18
3. Booth J.C., Rweyemamu M.M., and Pay T.W.F. Dose-response relationships in a micro-neutralization test for foot-and-mouth-disease viruses. J. Hygiene 80 (1978) 31-42
4. Brooksby J.B. Portraits of viruses-foot-and-mouth-disease virus. 8. Intervirology 18 (1982) 1-23
5. Cartwright B., Chapman W.G., and Sharpe R.T. Stimulation by heterotypic antigens of foot-and-mouth-disease virus-antibodies in vaccinated cattle. Res. Vet. Sci. 32 (1982) 338-342
6. Crowther J.R., Farias S., Carpenter W.C., and Samuel A.R. Identification of a 5th neutralizable site on type-O foot-and-mouth-disease virus following characterization of single and quintuple monoclonal-antibody escape mutants. J. Gen. Virol. 74 (1993) 1547-1553
7. Dunn C.S., Samuel A.R., Pullen L.A., and Anderson J. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease. Virology 247 (1998) 51-61
8. Ferris N.P., Abrescia N.G.A., Stuart D.I., Jackson T., Burman A., King D.P., and Paton D.J. Utility of recombinant integrin alpha v beta 6 as a capture reagent in immunoassays for the diagnosis of foot-and-mouth disease. J. Virol. Methods 127 (2005) 69-79
9. Garciabarreno B., Sanz A., Nogal M.L., Vinuela E., and Enjuanes L. Monoclonal-antibodies of African Swine fever virus-antigenic differences among field virus isolates and viruses passaged in cell-culture. J. Virol. 58 (1986) 385-392
10. Grazioli S., Fallacara F., and Brocchi E. Mapping of neutralisisng sites on FMD virus type Asia 1 and relationship with sites described in other serotypes. Open Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot and Mouth Disease. Chania, Crete, Greece, 11-15 October (2004) 277-287
11. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. Ser. 41 (1999) 95-98
12. Kitching R.P., Rendle R., and Ferris N.P. Rapid correlation between field isolates and vaccine strains of foot-and-mouth-disease virus. Vaccine 6 (1988) 403-408
13. Kitson J.D.A., McCahon D., and Belsham G.J. Sequence-analysis of monoclonal-antibody resistant mutants of type-O foot-and-mouth-disease virus-evidence for the involvement of the 3 surface exposed capsid proteins in 4 antigenic sites. Virology 179 (1990) 26-34
14. Knowles N.J., Samuel A.R., Davies P.R., Midgley R.J., and Valarcher J.F. Pandemic strain of foot-and-mouth disease virus serotype O. Emerging Infect. Dis. 11 (2005) 1887-1893
15. Lea S., Hernandez J., Blakemore W., Brocchi E., Curry S., Domingo E., Fry E., Abughazaleh R., King A., Newman J., Stuart D., and Mateu M.G. The structure and antigenicity of a type-C foot-and-mouth-disease virus. Structure 2 (1994) 123-139
16. Mattion N., Konig G., Seki C., Smitsaart E., Maradei E., Robiolo B., Duffy S., Leon E., Piccone M., Sadir A., Bottini R., Cosentino B., Falczuk A., Maresca R., Periolo O., Bellinzoni R., Espinoza A., La Torre J., and Palma E.L. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease. Vaccine 22 (2004) 4149-4162
17. Paton D.J., Valarcher J.F., Bergmann I., Matlho O.G., Zakharov V.M., Palma E.L., and Thomson G.R. Selection of foot and mouth disease vaccine strains-a review. Rev. Sci. Techn. Off. Int. Epizoot. 24 (2005) 981-993
18. Pay T.W.F., and Hingley P.J. Foot-and-mouth-disease vaccine potency tests in cattle - the interrelationship of antigen dose, serum neutralizing antibody-response and protection from challenge. Vaccine 10 10 (1992) 699-706 Erratum in: Vaccine 1993;11(3):392
19. Rweyemamu M.M., Booth J.C., Head M., and Pay T.W.F. Microneutralization tests for serological typing and subtyping of foot-and-mouth-disease virus-strains. J. Hygiene 81 (1978) 107-123
20. Rweyemamu M.M., and Hingley P.J. Foot and mouth-disease virus-strain differentiation-analysis of the serological data. J. Biol. Stand. 12 (1984) 225-229
21. Samuel A.R. Genetically diverse isolates of type O foot and mouth disease virus exhibit remarkable amino acid conservation at their neutralising antigenic sites. Open Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot and Mouth Disease. Borovets, Bulgaria, 5-8 September (2000) 67-79
22. Samuel A.R., and Knowles N.J. Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J. Gen. Virol. 82 (2001) 609-621
23. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 (1997) 4876-4882